Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human cytochrome P4501A2.

M T Landi1, R Sinha, N P Lang

  • 1Genetic Epidemiology Branch, Bethesda, MD 20892, USA.

IARC Scientific Publications
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

The British journal of dermatology·2018
Same author

Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.

Molecular psychiatry·2017
Same author

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence.

Translational psychiatry·2015

Individual differences in cytochrome P450 1A2 (CYP1A2) activity affect cancer risk and drug efficacy. Rapid CYP1A2 activity may increase the risk of colon and bladder cancers.

Area of Science:

  • Pharmacogenomics
  • Environmental Health
  • Cancer Epidemiology

Background:

  • Cytochrome P450 1A2 (CYP1A2) is crucial for metabolizing carcinogens and drugs.
  • Individual variations in CYP1A2 activity influence susceptibility to cancer and drug response.
  • CYP1A2 activity is regulated by constitutive expression and inducibility, with significant interindividual differences.

Purpose of the Study:

  • To investigate the relationship between CYP1A2 activity and cancer risk.
  • To explore factors influencing interindividual differences in CYP1A2 activity.
  • To evaluate methods for assessing CYP1A2 phenotype in epidemiological studies.

Main Methods:

  • Phenotyping CYP1A2 activity using caffeine as an in vitro probe.
  • Analyzing caffeine metabolites to determine CYP1A2 activity index.

Related Experiment Videos

  • Reviewing epidemiological studies on CYP1A2 activity and cancer risk.
  • Examining factors like gender, race, genetics, and environmental exposures affecting CYP1A2 activity.
  • Main Results:

    • Wide interindividual variations in CYP1A2 activity exist, influenced by gender, race, genetics, and inducers (e.g., smoking, diet, drugs).
    • Caffeine phenotyping shows variable distributions, with potential for bimodal or unimodal results.
    • Epidemiological data suggest a potential increased risk of colon and bladder cancer in individuals with rapid CYP1A2 activity.
    • Higher 4-aminobiphenyl-hemoglobin adducts observed in smokers with rapid CYP1A2 phenotype.

    Conclusions:

    • CYP1A2 activity is a significant factor in individual susceptibility to environmental carcinogens and drug metabolism.
    • Phenotyping CYP1A2 activity, particularly using caffeine, is valuable for epidemiological research despite methodological variations.
    • Further research is needed to elucidate the genetic and environmental determinants of CYP1A2 variability and its precise role in cancer development.